2650 related articles for article (PubMed ID: 18371393)
1. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.
Ginestier C; Hur MH; Charafe-Jauffret E; Monville F; Dutcher J; Brown M; Jacquemier J; Viens P; Kleer CG; Liu S; Schott A; Hayes D; Birnbaum D; Wicha MS; Dontu G
Cell Stem Cell; 2007 Nov; 1(5):555-67. PubMed ID: 18371393
[TBL] [Abstract][Full Text] [Related]
2. Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1.
Balicki D
Cell Stem Cell; 2007 Nov; 1(5):485-7. PubMed ID: 18938743
[No Abstract] [Full Text] [Related]
3. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.
Charafe-Jauffret E; Ginestier C; Iovino F; Tarpin C; Diebel M; Esterni B; Houvenaeghel G; Extra JM; Bertucci F; Jacquemier J; Xerri L; Dontu G; Stassi G; Xiao Y; Barsky SH; Birnbaum D; Viens P; Wicha MS
Clin Cancer Res; 2010 Jan; 16(1):45-55. PubMed ID: 20028757
[TBL] [Abstract][Full Text] [Related]
4. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells.
Lin L; Hutzen B; Lee HF; Peng Z; Wang W; Zhao C; Lin HJ; Sun D; Li PK; Li C; Korkaya H; Wicha MS; Lin J
PLoS One; 2013; 8(12):e82821. PubMed ID: 24376586
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer stem cells and intrinsic subtypes: controversies rage on.
Nakshatri H; Srour EF; Badve S
Curr Stem Cell Res Ther; 2009 Jan; 4(1):50-60. PubMed ID: 19149630
[TBL] [Abstract][Full Text] [Related]
7. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.
Vesuna F; Lisok A; Kimble B; Raman V
Neoplasia; 2009 Dec; 11(12):1318-28. PubMed ID: 20019840
[TBL] [Abstract][Full Text] [Related]
8. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.
Jiang F; Qiu Q; Khanna A; Todd NW; Deepak J; Xing L; Wang H; Liu Z; Su Y; Stass SA; Katz RL
Mol Cancer Res; 2009 Mar; 7(3):330-8. PubMed ID: 19276181
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase activity is a biomarker of primitive normal human mammary luminal cells.
Eirew P; Kannan N; Knapp DJ; Vaillant F; Emerman JT; Lindeman GJ; Visvader JE; Eaves CJ
Stem Cells; 2012 Feb; 30(2):344-8. PubMed ID: 22131125
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
Sullivan JP; Spinola M; Dodge M; Raso MG; Behrens C; Gao B; Schuster K; Shao C; Larsen JE; Sullivan LA; Honorio S; Xie Y; Scaglioni PP; DiMaio JM; Gazdar AF; Shay JW; Wistuba II; Minna JD
Cancer Res; 2010 Dec; 70(23):9937-48. PubMed ID: 21118965
[TBL] [Abstract][Full Text] [Related]
11. Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium.
Honeth G; Lombardi S; Ginestier C; Hur M; Marlow R; Buchupalli B; Shinomiya I; Gazinska P; Bombelli S; Ramalingam V; Purushotham AD; Pinder SE; Dontu G
Breast Cancer Res; 2014 May; 16(3):R52. PubMed ID: 24887554
[TBL] [Abstract][Full Text] [Related]
12. ALDH1 as a functional marker of cancer stem and progenitor cells.
Douville J; Beaulieu R; Balicki D
Stem Cells Dev; 2009; 18(1):17-25. PubMed ID: 18573038
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of stem cell markers ALDH1 and CD44 in non-malignant and neoplastic lesions of the breast.
DA Cruz Paula A; Marques O; Rosa AM; DE Fátima Faria M; Rêma A; Lopes C
Anticancer Res; 2014 Mar; 34(3):1427-34. PubMed ID: 24596390
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.
Huang EH; Hynes MJ; Zhang T; Ginestier C; Dontu G; Appelman H; Fields JZ; Wicha MS; Boman BM
Cancer Res; 2009 Apr; 69(8):3382-9. PubMed ID: 19336570
[TBL] [Abstract][Full Text] [Related]
15. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
Visus C; Wang Y; Lozano-Leon A; Ferris RL; Silver S; Szczepanski MJ; Brand RE; Ferrone CR; Whiteside TL; Ferrone S; DeLeo AB; Wang X
Clin Cancer Res; 2011 Oct; 17(19):6174-84. PubMed ID: 21856769
[TBL] [Abstract][Full Text] [Related]
16. Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells.
Lin JJ; Huang CS; Yu J; Liao GS; Lien HC; Hung JT; Lin RJ; Chou FP; Yeh KT; Yu AL
Breast Cancer Res; 2014 Mar; 16(2):R29. PubMed ID: 24670249
[TBL] [Abstract][Full Text] [Related]
17. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
[TBL] [Abstract][Full Text] [Related]
18. Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer.
Heerma van Voss MR; van der Groep P; Bart J; van der Wall E; van Diest PJ
Cell Oncol (Dordr); 2011 Feb; 34(1):3-10. PubMed ID: 21336637
[TBL] [Abstract][Full Text] [Related]
19. Identification of Breast Cancer Stem Cells Using a Newly Developed Long-acting Fluorescence Probe, C5S-A, Targeting ALDH1A1.
Okamoto A; Funakoshi Y; Oe M; Takai R; Suto H; Nagatani Y; Nishimura M; Imamura Y; Kunihisa T; Kiyota N; Miki K; Ohe K; Tanino H; Minami H
Anticancer Res; 2022 Mar; 42(3):1199-1205. PubMed ID: 35220209
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells.
Li Y; Zhang T; Korkaya H; Liu S; Lee HF; Newman B; Yu Y; Clouthier SG; Schwartz SJ; Wicha MS; Sun D
Clin Cancer Res; 2010 May; 16(9):2580-90. PubMed ID: 20388854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
